NL-OMON49815Not yet recruitingNot Applicable
Investigation of flare and remission in atopic dermatitis in an integrated longitudinal study: effects of systemic treatment with cyclosporine A - EXP-1392
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites40 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •- adult patient with a flare of atopic dermatitis
- •- insufficient response to topical steroids
- •- intention to start cyclosporine A treatment
Exclusion Criteria
- •- systemic treatment for AD with an immunosuppressive/immunomodulating/biologic
- •agent within last 4 weeks
- •- Chronic or acute infection requiring treatment with oral or intravenous
- •antibiotics, anti-virals, anti-parasitics, anti-protozoals, or anti-fungals
- •within 4 weeks before the screening visit or superficial skin infections within
- •1 week before the baseline visit.
Investigators
Similar Trials
Not yet recruiting
Unknown
Retrospective observational study of patients with atopic dermatitis in remission with Upadacitinib.Atopic DermatitisJPRN-UMIN000054106on-Profit Organization Health Institute Research of Skin300
Completed
Not Applicable
Clinical observation of patients with atopic dermatitis without using topical steroidsatopic dermatitisJPRN-UMIN000015781Tsurumai Kouen Clinic200
Recruiting
Not Applicable
Disease trajectories in Atopic Dermatitis and PsoriasisL40.0L20.8Other atopic dermatitisPsoriasis vulgarisDRKS00013504Klinik für Dermatologie, UKSH Campus Kiel300
Withdrawn
Phase 4
Investigation of Flare and Remission in Subjects With Atopic DermatitisAtopic DermatitisNCT03710044LEO Pharma
Completed
Not Applicable
Evaluation of symptomatic change of atopic dermatitis by intake of health foodHealthy adultJPRN-UMIN000033462Japan Clinical Trial Association54